<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
42292-007-10
</NDCCode>
<PackageDescription>
10 BLISTER PACK in 1 CARTON (42292-007-10) > 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (42292-007-01)
</PackageDescription>
<NDC11Code>
42292-0007-10
</NDC11Code>
<ProductNDC>
42292-007
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Bexarotene
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Bexarotene
</NonProprietaryName>
<DosageFormName>
CAPSULE, LIQUID FILLED
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20160415
</StartMarketingDate>
<EndMarketingDate>
20200131
</EndMarketingDate>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA203174
</ApplicationNumber>
<LabelerName>
Mylan Institutional Inc.
</LabelerName>
<SubstanceName>
BEXAROTENE
</SubstanceName>
<StrengthNumber>
75
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
Retinoid [EPC],Retinoids [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2020-02-01
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
20160415
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20200131
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>